Qibin Zhang Selected Research

Glycated Proteins

2/2009	A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: probing the pathogenesis of chronic disease.
5/2008	Proteomic profiling of nonenzymatically glycated proteins in human plasma and erythrocyte membranes.
6/2007	Enrichment and analysis of nonenzymatically glycated peptides: boronate affinity chromatography coupled with electron-transfer dissociation mass spectrometry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qibin Zhang Research Topics

Disease

8	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2021 - 08/2010
8	Diabetes Complications 11/2018 - 01/2007
6	Diabetes Mellitus 01/2022 - 01/2007
4	Infections 10/2021 - 01/2010
4	Inflammation (Inflammations) 10/2021 - 01/2019
3	Type 2 Diabetes Mellitus (MODY) 01/2019 - 05/2008
2	Dysbiosis 07/2022 - 01/2020
2	Fibrosis (Cirrhosis) 07/2022 - 01/2010
2	Virus Diseases (Viral Diseases) 10/2021 - 01/2014
2	Fatty Liver 01/2020 - 01/2020
2	Pathologic Processes 01/2019 - 11/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2009 - 06/2007
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Insulinoma 01/2022
1	Body Weight (Weight, Body) 10/2021
1	Hepatitis 10/2021
1	Hepatitis A (Hepatitis, Infectious) 10/2021
1	Alcoholic Hepatitis 10/2021
1	Alcoholic Fatty Liver 01/2020
1	Insulin Resistance 01/2019
1	Crohn Disease (Crohn's Disease) 08/2015
1	Pathologic Constriction (Stenosis) 08/2015
1	Ulcerative Colitis 08/2015
1	Hyperglycemia 07/2011
1	Neoplasms (Cancer) 12/2009
1	Chronic Disease (Chronic Diseases) 02/2009
1	Glucose Intolerance 05/2008

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2007
7	Peptides (Polypeptides)IBA 01/2022 - 01/2007
6	LipidsIBA 01/2020 - 08/2010
4	Blood Proteins (Serum Proteins)IBA 03/2021 - 01/2013
3	Insulin (Novolin)FDA Link 01/2022 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 09/2019 - 12/2009
3	Glycated ProteinsIBA 02/2009 - 06/2007
3	Glucose (Dextrose)FDA LinkGeneric 05/2008 - 01/2007
2	GangliosidesIBA 10/2021 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2020 - 01/2010
2	OxylipinsIBA 01/2020 - 01/2019
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 07/2022
1	Immunoglobulin E (IgE)IBA 07/2022
1	Liposomes (Liposome)IBA 07/2022
1	ChitosanIBA 07/2022
1	Ribosomal DNA (rDNA)IBA 07/2022
1	Emodin (Archin)IBA 07/2022
1	RotenoneIBA 01/2022
1	ThapsigarginIBA 01/2022
1	LigandsIBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022
1	ChemokinesIBA 10/2021
1	miglustat (Zavesca)FDA Link 10/2021
1	Alanine Transaminase (SGPT)IBA 10/2021
1	Antiviral Agents (Antivirals)IBA 10/2021
1	CatalaseIBA 10/2021
1	GlucosidasesIBA 10/2021
1	Polysaccharides (Glycans)IBA 10/2021
1	CytokinesIBA 10/2021
1	Interferon Receptors (Interferon Receptor)IBA 10/2021
1	Cytokine Receptors (Cytokine Receptor)IBA 10/2021
1	ZincIBA 01/2020
1	Chemokine CXCL1IBA 01/2020
1	lysophosphatidic acidIBA 01/2020
1	sialogangliosidesIBA 01/2020
1	DefensinsIBA 01/2020
1	Lipocalin-2IBA 01/2020
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2019
1	AutoantibodiesIBA 10/2018
1	ProteomeIBA 08/2015
1	RNA (Ribonucleic Acid)IBA 01/2014
1	EnzymesIBA 01/2010
1	Advanced Glycation End ProductsIBA 02/2009
1	Tyrosine (L-Tyrosine)FDA Link 06/2007
1	benzeneboronic acidIBA 06/2007

Therapy/Procedure

2	Glycemic Control 03/2021 - 01/2020
1	Therapeutics 07/2022
1	Enema (Enemas) 07/2022
1	Immunotherapy 01/2022